The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection in the Neonatal Period

Abstract

Objective Respiratory syncytial virus (RSV) is the most common viral respiratory infection in infants. This study aimed to establish the potential changes in the clinical course of RSV in the neonatal period with the onset of the coronavirus disease 2019(COVID-19) pandemic.

Study Design During the observational study period, newborns diagnosed with community-acquired RSV infection and admitted to the neonatal intensive care unit (NICU) were evaluated. RSV-infected neonates before the COVID-19 pandemic were classified as Group 1, those during the strict isolation period as Group 2, and RSV-infected newborns after the removal of restrictions were classified as Group 3.

Results A total of 208 community-acquired RSV-infected neonates were analyzed. The median age at admission to the NICU was 26 days, and the mean gestational week was 37.2 ± 2.7. The ratio of hospitalized babies with RSV infection to all hospitalized newborns rose after the pandemic significantly (1.9, 1.6, 5.2%; p < 0.001). Following the pandemic, there was an increase in full-term, early-term, and late-preterm cases. Nevertheless, no change was observed in the number of preterm cases (p > 0.05). There was also a statistically significant increase in the need for intubation, noninvasive ventilation (NIV), supplemental oxygen, inhaled bronchodilator drugs, and length of hospital stay in Group 3 after the pandemic (p < 0.001). All these parameters related to more severe RSV infection when the precautions were removed, while there was a milder disease with restrictions during the pandemic in Group 2 (p < 0.001). However, none died due to RSV infection during the study because of timely supportive care.

Conclusion Following the COVID-19 pandemic, the frequency and severity of RSV infection in newborns have increased, and it can result in a serious clinical picture even in full-term babies with no comorbidities. Attention to strict contact precautions, particularly in newborns, who are a more vulnerable population after the pandemic, may play an important role in any future outbreak.

Key Points

• The course of neonatal RSV infection has changed after the pandemic.

• A statistically significant increase was observed in the need of intubation in newborns with RSV.

• The strict precautions during the pandemic also helped to prevent the transmission of RSV.

Keywords

COVID-19 - newborn - pandemic - respiratory syncytial virus

Authors' Contribution

Conceptualization, S.A.A., S.C., Y.A., and T.G.Y.; writing, S.A.A.; review and editing, S.A.A., B.S., E.Y.E., O.H.K., and S.A.O; supervision, S.C. and T.G.Y. All authors have read and agreed to the published version of the manuscript.

Publication History

Received: 09 August 2023

Accepted: 22 January 2024

Accepted Manuscript online:
25 January 2024

Article published online:
26 February 2024

• References

• 1 Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143 (5 suppl) S127-S132
• 2 Turkish Neonatal Society. The seasonal variations of respiratory syncytial virus infections in Turkey: a 2-year epidemiological study. Turk J Pediatr 2012; 54 (03) 216-222
• 3 Stein RT, Bont LJ, Zar H. et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol 2017; 52 (04) 556-569
• 4 World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report 5. 2020. Accessed January 25, 2020 at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_8
• 5 Guitart C, Bobillo-Perez S, Alejandre C. et al; Hospital Network for R. S. V. surveillance in Catalonia. Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic. BMC Infect Dis 2022; 22 (01) 84
• 6 Garg I, Shekhar R, Sheikh AB, Pal S. Impact of COVID-19 on the changing patterns of respiratory syncytial virus infections. Infect Dis Rep 2022; 14 (04) 558-568
• 7 Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A 2020; 117 (48) 30547-30553
• 8 Zheng Z, Pitzer VE, Shapiro ED, Bont LJ, Weinberger DM. Estimation of the timing and intensity of reemergence of respiratory syncytial virus following the COVID-19 pandemic in the US. JAMA Netw Open 2021; 4 (12) e2141779
• 9 Li Y, Wang X, Cong B, Deng S, Feikin DR, Nair H. Understanding the potential drivers for respiratory syncytial virus rebound during the coronavirus disease 2019 pandemic. J Infect Dis 2022; 225 (06) 957-964
• 10 Qiu W, Zheng C, Huang S, Zhang Y, Chen Z. Epidemiological trend of RSV infection before and during COVID-19 pandemic: a three-year consecutive study in China. Infect Drug Resist 2022; 15: 6829-6837
• 11 Poole S, Brendish NJ, Clark TW. SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study. J Infect 2020; 81 (06) 966-972
• 12 Nascimento MS, Baggio DM, Fascina LP, do Prado C. Impact of social isolation due to COVID-19 on the seasonality of pediatric respiratory diseases. PLoS One 2020; 15 (12) e0243694
• 13 Kim JH, Roh YH, Ahn JG. et al. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int J Infect Dis 2021; 110: 29-35
• 14 Mosscrop LG, Williams TC, Tregoning JS. Respiratory syncytial virus after the SARS-CoV-2 pandemic - what next?. Nat Rev Immunol 2022; 22 (10) 589-590
• 15 Cohen R, Ashman M, Taha MK. et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?. Infect Dis Now 2021; 51 (05) 418-423
• 16 Weinberger Opek M, Yeshayahu Y, Glatman-Freedman A, Kaufman Z, Sorek N, Brosh-Nissimov T. Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021. Euro Surveill 2021; 26 (29) 2100706
• 17 Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis 2021; 27 (11) 2969-2970
• 18 Alan S, Erdeve O, Cakir U. et al; TurkNICU-RSV Trial Group. Outcome of the Respiratory Syncytial Virus related acute lower respiratory tract infection among hospitalized newborns: a prospective multicenter study. J Matern Fetal Neonatal Med 2016; 29 (13) 2186-2193
• 19 Saravanos GL, Hu N, Homaira N. et al. RSV epidemiology in Australia before and during COVID-19. Pediatrics 2022; 149 (02) e2021053537
• 20 Takashita E, Kawakami C, Momoki T. et al. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses 2021; 15 (04) 488-494